Investing Profile

Brent Ahrens

VCInvestor

General Partner at Canaan Partners

canaan.com/team/brent-ahrensMenlo Park, California
Photo of Brent Ahrens, General Partner at Canaan Partners
Your Intro Paths to Brent Ahrens

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Brent Ahrens on

cb
Current Investing Position
Canaan Partners General Partner
Investment Range
$250K - $20.0M
Sweet Spot
$10.0M
Investments On Record
33
Current Fund Size
$800M

Brent Ahrens is on these Sector & Stage Rankings

Brent Ahrens's Investments On Record (15)

CompanyStageDateRound SizeTotal Raised
Grey Wolf Therapeutics
Series AFeb 2019£10M
£10M
Unchained Labs
Series CJun 2017$13M
Series AFeb 2015$25M
$38M
Iterum Therapeutics
Series BMay 2017$65M
Series AMar 2016$40M
$110M
Co-investors: Mark Chin (Arix Bioscience)
Abyrx
Venture RoundDec 2016$10M
$10M
Relievant Medsystems
Series DOct 2016$36M
Series DMar 2012$30M
Series CJul 2009$20M
$160M
Co-investors: Justin Klein (Vensana Capital), Jason Lettmann (Morgenthaler Ventures)
EndoGastric Solutions
Venture RoundDec 2015$50M
Series GMay 2014$30M
Venture RoundJun 2012$13M
Venture RoundApr 2012$2.1M
Series GMar 2012$11M
Series FAug 2010$30M
$190M
Co-investors: Mike Carusi (Lightstone Ventures)
Minimally invasive devices
Series CNov 2015$14M
Debt FinancingJun 2014$6M
Series BJun 2013$2.5M
Series BMar 2013$9M
$32M
Co-investors: Wende Hutton (Canaan Partners)
Spinifex Pharmaceuticals
Series CApr 2014$45M
$45M
Co-investors: Heath Lukatch (Red Tree Venture Capital)